ConductScience.org, home
A Study to Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis
API referenceFor AI assistants

Trial · NCT03598790

Participant flow54

How many started, completed or left each group, period by period.

1 to 20 of 54

Download this page as JSON
PeriodMilestoneGroupParticipantsUnits counted
Treatment Period (TP): Wk0-Wk144STARTEDCohort A: BKZ 320 mg Q8W384
Treatment Period (TP): Wk0-Wk144STARTEDCohort A: BKZ 320 mg Q4W/Q8W833
Treatment Period (TP): Wk0-Wk144STARTEDCohort A: BKZ 320 mg Q4W70
Treatment Period (TP): Wk0-Wk144STARTEDCohort A: Group A BKZ 320 mg Q8W0
Treatment Period (TP): Wk0-Wk144STARTEDCohort A: Group B BKZ 320 mg Q8W0
Treatment Period (TP): Wk0-Wk144STARTEDCohort A: Group B BKZ 320 mg Q4W/Q8W0
Treatment Period (TP): Wk0-Wk144STARTEDCohort B: PSO BKZ Total45
Treatment Period (TP): Wk0-Wk144STARTEDCohort B: EP BKZ Total11
Treatment Period (TP): Wk0-Wk144STARTEDCohort B: GPP BKZ Total10
Treatment Period (TP): Wk0-Wk144COMPLETEDCohort A: BKZ 320 mg Q8W326
Treatment Period (TP): Wk0-Wk144COMPLETEDCohort A: BKZ 320 mg Q4W/Q8W746
Treatment Period (TP): Wk0-Wk144COMPLETEDCohort A: BKZ 320 mg Q4W0
Treatment Period (TP): Wk0-Wk144COMPLETEDCohort A: Group A BKZ 320 mg Q8W0
Treatment Period (TP): Wk0-Wk144COMPLETEDCohort A: Group B BKZ 320 mg Q8W0
Treatment Period (TP): Wk0-Wk144COMPLETEDCohort A: Group B BKZ 320 mg Q4W/Q8W0
Treatment Period (TP): Wk0-Wk144COMPLETEDCohort B: PSO BKZ Total38
Treatment Period (TP): Wk0-Wk144COMPLETEDCohort B: EP BKZ Total10
Treatment Period (TP): Wk0-Wk144COMPLETEDCohort B: GPP BKZ Total8
Treatment Period (TP): Wk0-Wk144NOT COMPLETEDCohort A: BKZ 320 mg Q8W58
Treatment Period (TP): Wk0-Wk144NOT COMPLETEDCohort A: BKZ 320 mg Q4W/Q8W87

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Next page

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03598790/flow

API referenceFor AI assistants